Prosecution Insights
Last updated: July 17, 2026
Application No. 18/837,062

NOVEL COMPOSITIONS FOR REDUCING METHANE PRODUCTION IN RUMINANT ANIMALS

Non-Final OA §103
Filed
Aug 08, 2024
Priority
Feb 09, 2022 — AU 2022900266 +1 more
Examiner
JAVANMARD, SAHAR
Art Unit
1622
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Futurefeed Pty Ltd.
OA Round
1 (Non-Final)
65%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
484 granted / 742 resolved
+5.2% vs TC avg
Strong +35% interview lift
Without
With
+34.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
46 currently pending
Career history
782
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
75.5%
+35.5% vs TC avg
§102
8.8%
-31.2% vs TC avg
§112
8.3%
-31.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 742 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Claims This Office Action is in response to Applicant's Restriction Requirement remarks filed on June 1, 2026. Claim(s) 51-69 are pending. Claim(s) 56-61 and 63-67 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Applicant's election of Group I drawn to a method of reducing total gas production and/or methane production with traverse of the restriction requirement in the reply is acknowledged. The traversal is based on undue search burden. Examiner respectfully notes that search burden is not a standard for unity of invention. The requirement is deemed proper and is therefore made FINAL. Claim(s) 51-55, 62, and 68-69 are examined herein insofar as they read on the elected invention. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 51-55, 62, and 68-69 are rejected under 35 U.S.C. 103 as being unpatentable over Grass (US Patent 3,660,562) of record. Grass teaches a ruminant feed composition and methods of improving the efficiency in ruminants by feeding them volatile polyhalohydrocarbons that are micro-coated using various resins so to inhibit methanogenesis (column 2, lines 37-42). Grass teaches the volatile methane inhibitors include bromoform that is premixed into animal feed along with carriers such as soybean meal, corn oil, ground corn, barley, wheat and soyflour (column 4, lines 25-30; lines 40-71). Grass teaches the effect of encapsulating or coating polyhalogenated volatile liquid or solid compounds is to reducing methane production without causing a reduction in the rate of overall fermentation. The study was designed to observe the suppression of methane in rumen gas samples and the change in volatile fatty acids in rumen liquid samples (column 5, lines 55-63). Grass teaches the ruminant feeds are specifically for cattle or sheep and that the feed can either be a solid additive or encapsulated liquid and that they also comprise other cellulosic roughage and excipients (column 4, lines 40-50). Grass indicates the major disadvantage of the chlorine-containing analogues of methane is that they are volatile liquids with a characteristic unpleasant odor and taste (column 2, lines 12-24). Grass is silent on formulations which contain compounds selected from iodine, bromine, dibromochloromethane, bromochloroacetic acid, and dibromoacetic acid, as required by the limitations of claim 69 (see whole document), therefore the limitations of claim 69 are met. Grass teaches the animal feeds themselves may also contain cellulosic roughage such as cellulose, hay, stray, corn stalks, cotton seed hulls, oats, barley and cereal brans, natural oils, such as, for example, animal fats, fish oils, safflower oil, peanut oil and cottonseed oil, antioxidants, minerals, vitamins, antibiotics, anthelmintics and other appropriate medicaments (column 5, lines 1-7). The difference between Grass and the claimed invention is that it does not teach the invention with particularity so as to amount to anticipation (See M.P.E.P. § 2131: "[t]he identical invention must be shown in as complete detail as is contained in the ... claim." Richardson v. Suzuki Motor Co., 868 F.2d 1226, 1236, 9 USPQ2d 1913, 1920 (Fed. Cir. 1989). The elements must be arranged as required by the claim, but this is not an ipsissimis verbis test, i.e., identity of terminology is not required. In re Bond, 910 F.2d 831,15 USPQ2d 1566 (Fed. Cir. 1990)). However, based on the above, Grass teaches the elements of the claimed invention with sufficient guidance, particularity, and with a reasonable expectation of success, that the invention would be prima facie obvious to one of ordinary skill (the prior art reference teaches or suggests all the claim limitations with a reasonable expectation of success. See M.P.E.P. § 2143). Therefore, based on the foregoing reasons, the instant claims are deemed unpatentable over the cited art. Conclusion Claims 51-55, 62, and 68-69 are not allowed. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Sahar Javanmard whose telephone number is (571)270-3280. The examiner can normally be reached on Monday-Friday, 9:00-5:00 EST. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, James Alstrum-Acevedo can be reached on 571-272-5548. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. /SAHAR JAVANMARD/Primary Examiner, Art Unit 1622
Read full office action

Prosecution Timeline

Aug 08, 2024
Application Filed
Jun 23, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12673956
OXADIAZOLYL DIHYDROPYRANO[2,3-b]PYRIDINE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS
2y 11m to grant Granted Jul 07, 2026
Patent 12667563
PROPHYLACTIC OR THERAPEUTIC AGENT FOR PORPHYRIA
3y 6m to grant Granted Jun 30, 2026
Patent 12661352
COMBINATION THERAPY WITH CLK/DYRK INHIBITORS AND BCL2 INHIBITORS TO TREAT LEUKEMIA
10m to grant Granted Jun 23, 2026
Patent 12653819
FORMULATIONS AND TREATMENT METHODS
4y 3m to grant Granted Jun 16, 2026
Patent 12653855
OPTIMIZING VOLATILE ENTOURAGES IN DRY FLOWERING PLANT MIXTURES
3y 1m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
99%
With Interview (+34.8%)
2y 10m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 742 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month